Matches in Wikidata for { <http://www.wikidata.org/entity/Q82612984> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q82612984 description "article scientifique publié en 2011" @default.
- Q82612984 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q82612984 description "im Oktober 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82612984 description "scientific article published on 25 October 2011" @default.
- Q82612984 description "wetenschappelijk artikel" @default.
- Q82612984 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q82612984 name "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 name "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 type Item @default.
- Q82612984 label "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 label "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 prefLabel "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 prefLabel "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 P1433 Q82612984-8784EC96-2B2E-4D9F-88E4-F6F6177A68E3 @default.
- Q82612984 P1476 Q82612984-CC1CACB5-0088-4482-BF6C-10612ED186A5 @default.
- Q82612984 P2093 Q82612984-00C8687B-2F44-4472-B0BE-CE7E514E6ED9 @default.
- Q82612984 P2093 Q82612984-0900B340-2BD9-4A5D-B91D-3628F62D066B @default.
- Q82612984 P2093 Q82612984-16CE91E3-892E-4671-BA3F-A89291CA400B @default.
- Q82612984 P2093 Q82612984-3FFCFBAE-DCA3-4846-B62E-9872D3B4D20E @default.
- Q82612984 P2093 Q82612984-46A80E2C-5807-4532-9D33-94F5C2504FF7 @default.
- Q82612984 P2093 Q82612984-7872C045-F242-424B-BEC1-A26C8C6EA3A2 @default.
- Q82612984 P2093 Q82612984-C088E5EA-0F52-413F-B81F-1B1C5057CD42 @default.
- Q82612984 P2093 Q82612984-E139EC73-9BE1-4EB0-8260-6597CA7BEE5A @default.
- Q82612984 P304 Q82612984-09E03D21-498E-439C-802F-28A162502CD1 @default.
- Q82612984 P31 Q82612984-E50E4B8C-97F5-4C2A-9296-E87DF5EA91D8 @default.
- Q82612984 P356 Q82612984-FEE25307-265F-4CAB-9EF9-DD70FC2F0B74 @default.
- Q82612984 P433 Q82612984-C8B212DF-6652-4684-AB9E-EAE7F8A8E83B @default.
- Q82612984 P478 Q82612984-4E7CB466-D4AA-4473-8D44-EA55C9A99B04 @default.
- Q82612984 P577 Q82612984-CA70F2CA-5373-49FE-BE0B-7DCDEA27BBAF @default.
- Q82612984 P698 Q82612984-CB1A581D-1478-4408-A274-AC4492812BCF @default.
- Q82612984 P921 Q82612984-D3F3555F-C115-41ED-84F5-9E7D6EF74826 @default.
- Q82612984 P356 J.BMCL.2011.10.066 @default.
- Q82612984 P698 22104142 @default.
- Q82612984 P1433 Q2709483 @default.
- Q82612984 P1476 "Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8" @default.
- Q82612984 P2093 "Elizabeth Farrant" @default.
- Q82612984 P2093 "Inaki Morao" @default.
- Q82612984 P2093 "M Abid Masood" @default.
- Q82612984 P2093 "Manuel Perez" @default.
- Q82612984 P2093 "Marc Bazin" @default.
- Q82612984 P2093 "Mark E Bunnage" @default.
- Q82612984 P2093 "Sally-Ann Fancy" @default.
- Q82612984 P2093 "Torren Peakman" @default.
- Q82612984 P304 "723-728" @default.
- Q82612984 P31 Q13442814 @default.
- Q82612984 P356 "10.1016/J.BMCL.2011.10.066" @default.
- Q82612984 P433 "1" @default.
- Q82612984 P478 "22" @default.
- Q82612984 P577 "2011-10-25T00:00:00Z" @default.
- Q82612984 P698 "22104142" @default.
- Q82612984 P921 Q411240 @default.